Related references
Note: Only part of the references are listed.Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis
Kevin G. Friedman et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2021)
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis
Jacob Pendergrast et al.
TRANSFUSION (2021)
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
Jane C. Burns et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management
Lauren A. Henderson et al.
PEDIATRIC DRUGS (2020)
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Elizabeth Whittaker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
Eva W. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products
Christine W. Bruggeman et al.
BLOOD ADVANCES (2020)
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City
Shubhi Kaushik et al.
JOURNAL OF PEDIATRICS (2020)
Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
Zhouping Wang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
Hiromichi Hamada et al.
LANCET (2019)
Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease
Han Chan et al.
BMC PEDIATRICS (2019)
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
Samantha C. Roberts et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis
Audrey Dionne et al.
PEDIATRICS (2019)
Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days
Ya-Chiao Hu et al.
FRONTIERS IN PEDIATRICS (2019)
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population
Mary Beth F. Son et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort
Marianna Fabi et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Role of intravenous immunoglobulin in the treatment of Kawasaki disease
Mindy S. Lo et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999-2010 in Japan
Ryuji Fukazawa et al.
CIRCULATION JOURNAL (2018)
Arthritis in Kawasaki disease: A poorly recognised manifestation
Andreia Martins et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)
The Aspirin-NSAID Interaction More Data, But a Lack of Clarity Remains
Elliott M. Antman
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events
Masaru Miura et al.
JAMA PEDIATRICS (2018)
High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease
Andrea P. Salgado et al.
JOURNAL OF PEDIATRICS (2017)
Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes
Gi Beom Kim et al.
JOURNAL OF PEDIATRICS (2017)
Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease
Frederic Dallaire et al.
PEDIATRICS (2017)
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores
Mary Beth F. Son et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance
Paul E. Alexander et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population
Kevin G. Friedman et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Macrophage activation syndrome in Kawasaki Disease: More common than we thought?
Wei Wang et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
Adriana H. Tremoulet et al.
LANCET (2014)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
Jeff Andrews et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease
Tohru Kobayashi et al.
JOURNAL OF PEDIATRICS (2013)
Steroid Pulse Therapy for Children With Intravenous Immunoglobulin Therapy-Resistant Kawasaki Disease: A Prospective Study
Masayuki Teraguchi et al.
PEDIATRIC CARDIOLOGY (2013)
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
Tohru Kobayashi et al.
LANCET (2012)
Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study
Jan Marc Orenstein et al.
PLOS ONE (2012)
Preventing Coronary Artery Abnormalities: A Need for Earlier Diagnosis and Treatment of Kawasaki Disease
Samuel R. Dominguez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Late Intravenous Immunoglobulin Treatment in Patients With Kawasaki Disease
Hiromi Muta et al.
PEDIATRICS (2012)
Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy
Masaru Miura et al.
PAEDIATRICS & CHILD HEALTH (2011)
Macrophage Activation Syndrome in the Acute Phase of Kawasaki Disease
Giuseppe A. Latino et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease
Elizabeth S. Yellen et al.
PEDIATRICS (2010)
Kawasaki Disease at the Extremes of the Age Spectrum
Cedric Manlhiot et al.
PEDIATRICS (2009)
Recognition of a Kawasaki Disease Shock Syndrome
John T. Kanegaye et al.
PEDIATRICS (2009)
Resistance to intravenous immunoglobulin in children with Kawasaki disease
Adriana H. Tremoulet et al.
JOURNAL OF PEDIATRICS (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease
T. Furukawa et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2008)
Prevalence of coronary artery abnormality in incomplete Kawasaki disease
Tomoyoshi Sonobe et al.
PEDIATRICS INTERNATIONAL (2007)
Coronary artery involvement in children with Kawasaki disease - Risk factors from analysis of serial normalized measurements
Brian W. McCrindle et al.
CIRCULATION (2007)
Arthritis presenting during the acute phase of Kawasaki disease
Grace W. K. Gong et al.
JOURNAL OF PEDIATRICS (2006)
Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment
KY Lee et al.
EUROPEAN JOURNAL OF PEDIATRICS (2005)
Share Paper
